301097 天益医疗
已收盘 03-02 15:00:00
资讯
新帖
简况
天益医疗：截至2026年2月13日，公司股东总数为4,958户
证券之星 · 02-25
天益医疗：截至2026年2月13日，公司股东总数为4,958户
天益医疗：公司泰国项目的建设目前正按计划进度有序推进
证券之星 · 02-11
天益医疗：公司泰国项目的建设目前正按计划进度有序推进
股市必读：天益医疗(301097)股东户数0.52万户，较上期减少9.32%
证券之星 · 02-04
股市必读：天益医疗(301097)股东户数0.52万户，较上期减少9.32%
天益医疗：公司于2024年10月与费森尤斯子公司ProCure Medical GmbH签订的《分销合同》正正常履行中
证券之星 · 02-03
天益医疗：公司于2024年10月与费森尤斯子公司ProCure Medical GmbH签订的《分销合同》正正常履行中
天益医疗(301097.SZ)：“血液透析浓缩物”取得产品注册证书
智通财经 · 01-30
天益医疗(301097.SZ)：“血液透析浓缩物”取得产品注册证书
股市必读：天益医疗(301097)股东户数0.57万户，较上期增加10.93%
证券之星 · 01-30
股市必读：天益医疗(301097)股东户数0.57万户，较上期增加10.93%
天益医疗：截至2026年1月20日，公司股东数量共计5,696名
证券之星 · 01-29
天益医疗：截至2026年1月20日，公司股东数量共计5,696名
信达证券：首次覆盖天益医疗给予买入评级
证券之星 · 01-27
信达证券：首次覆盖天益医疗给予买入评级
天益医疗获医疗器械注册证 承担血液及液体通路功能
财中社 · 01-19
天益医疗获医疗器械注册证 承担血液及液体通路功能
天益医疗(301097.SZ)新产品取得产品注册证书
智通财经 · 01-19
天益医疗(301097.SZ)新产品取得产品注册证书
天益医疗(301097.SZ)拟6000万元至1.2亿元回购公司股份
智通财经 · 01-12
天益医疗(301097.SZ)拟6000万元至1.2亿元回购公司股份
天益医疗（301097）披露更换保荐代表人公告，12月26日股价上涨0.42%
证券之星 · 2025-12-26
天益医疗（301097）披露更换保荐代表人公告，12月26日股价上涨0.42%
天益医疗（301097）披露董事会完成换届选举及聘任高级管理人员公告，12月15日股价上涨2.43%
证券之星 · 2025-12-15
天益医疗（301097）披露董事会完成换届选举及聘任高级管理人员公告，12月15日股价上涨2.43%
天益医疗：截至2025年12月10日股东数为5,135户
证券之星 · 2025-12-11
天益医疗：截至2025年12月10日股东数为5,135户
天益医疗（301097）披露选举第四届董事会成员，12月08日股价下跌2.33%
证券之星 · 2025-12-08
天益医疗（301097）披露选举第四届董事会成员，12月08日股价下跌2.33%
天益医疗(301097)11月20日股东户数0.52万户，较上期减少8.49%
证券之星 · 2025-11-24
天益医疗(301097)11月20日股东户数0.52万户，较上期减少8.49%
11月21日天益医疗跌5.93%，鹏华安和混合A基金重仓该股
证券之星 · 2025-11-21
11月21日天益医疗跌5.93%，鹏华安和混合A基金重仓该股
天益医疗（301097）披露新产品取得产品注册证书，11月20日股价上涨1.58%
证券之星 · 2025-11-20
天益医疗（301097）披露新产品取得产品注册证书，11月20日股价上涨1.58%
天益医疗(301097.SZ)子公司血液透析浓缩物取得产品注册证书
智通财经 · 2025-11-20
天益医疗(301097.SZ)子公司血液透析浓缩物取得产品注册证书
11月19日天益医疗跌5.35%，鹏华安和混合A基金重仓该股
证券之星 · 2025-11-19
11月19日天益医疗跌5.35%，鹏华安和混合A基金重仓该股
加载更多
公司概况
公司名称：
宁波天益医疗器械股份有限公司
所属行业：
专用设备制造业
上市日期：
2022-04-07
主营业务：
宁波天益医疗器械股份有限公司的主营业务是血液净化及病房护理领域医用高分子耗材等医疗器械的研发、生产与销售。公司的主要产品是血液净化装置的体外循环血路、一次性使用动静脉穿刺器、血液透析浓缩液/血液透析干粉、一次性使用一体式吸氧管、喂食器及喂液管。
发行价格：
52.37
{"stockData":{"symbol":"301097","market":"SZ","secType":"STK","nameCN":"天益医疗","latestPrice":56.86,"timestamp":1772435019000,"preClose":58.05,"halted":0,"volume":878100,"delay":0,"changeRate":-0.0205,"floatShares":28941400,"shares":58947400,"eps":0.2207,"marketStatus":"已收盘","change":-1.19,"latestTime":"03-02 15:00:00","open":58,"high":58.5,"low":56.77,"amount":50367900,"amplitude":0.0298,"askPrice":57.21,"askSize":1,"bidPrice":56.86,"bidSize":11,"shortable":0,"etf":0,"ttmEps":0.2207,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772501400000},"marketStatusCode":5,"adr":0,"adjPreClose":58.05,"symbolType":"stock","openAndCloseTimeList":[[1772415000000,1772422200000],[1772427600000,1772434800000]],"highLimit":63.86,"lowLimit":52.25,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":58947368,"isCdr":false,"pbRate":2.9,"roa":"--","peRate":257.634798,"roe":"1.7%","epsLYR":-0.01,"committee":0.647059,"marketValue":3352000000,"turnoverRate":0.0303,"status":1,"floatMarketCap":1646000000},"requestUrl":"/m/hq/s/301097","defaultTab":"news","newsList":[{"id":"2614025776","title":"天益医疗：截至2026年2月13日，公司股东总数为4,958户","url":"https://stock-news.laohu8.com/highlight/detail?id=2614025776","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614025776?lang=zh_cn&edition=full","pubTime":"2026-02-25 11:36","pubTimestamp":1771990584,"startTime":"0","endTime":"0","summary":"证券之星消息，天益医疗(301097)02月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最近一期公司的股东人数是多少？天益医疗回复：尊敬的投资者，您好，截至2026年2月13日，公司股东总数为4,958户，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500015584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2610603595","title":"天益医疗：公司泰国项目的建设目前正按计划进度有序推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2610603595","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610603595?lang=zh_cn&edition=full","pubTime":"2026-02-11 08:51","pubTimestamp":1770771070,"startTime":"0","endTime":"0","summary":"公司泰国项目的建设目前正按计划进度有序推进，预计将于2026年6月30日前达到预定可使用状态，具体内容详见公司在中国证监会指定创业板信息披露网站巨潮资讯网上发布的《关于部分募投项目延期的公告》。公司将加快泰国项目建设进度，并严格按照相关法律法规履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100005971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2608758804","title":"股市必读：天益医疗(301097)股东户数0.52万户，较上期减少9.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608758804","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608758804?lang=zh_cn&edition=full","pubTime":"2026-02-04 03:05","pubTimestamp":1770145514,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，天益医疗报收于56.22元，下跌1.56%，换手率5.04%，成交量1.46万手，成交额8113.93万元。来自股本股东变化：截至1月30日股东户数环比下降9.32%，户均持股数量升至1.14万股。股本股东变化股东户数变动近日天益医疗披露，截至2026年1月30日公司股东户数为5165.0户，较1月20日减少531.0户，减幅为9.32%。户均持股数量由上期的1.03万股增加至1.14万股，户均持股市值为68.4万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400001784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2608961843","title":"天益医疗：公司于2024年10月与费森尤斯子公司ProCure Medical GmbH签订的《分销合同》正正常履行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2608961843","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608961843?lang=zh_cn&edition=full","pubTime":"2026-02-03 11:33","pubTimestamp":1770089632,"startTime":"0","endTime":"0","summary":"证券之星消息，天益医疗(301097)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请查询最新一期股东人数，公司24年签署的合同订单目前履行进展情况如何？天益医疗回复：1、截至2026年1月30日，公司股东总数为5,165户2、公司于2024年10月与费森尤斯子公司ProCure Medical GmbH签订的《分销合同》正正常履行中，2026年为合同正式生效首年，公司将按约定安排陆续交付产品以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300016097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2607115062","title":"天益医疗(301097.SZ)：“血液透析浓缩物”取得产品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2607115062","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607115062?lang=zh_cn&edition=full","pubTime":"2026-01-30 11:50","pubTimestamp":1769745000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天益医疗(301097.SZ)发布公告，公司子公司宁波天益药业科技有限公司(以下简称“天益药业”)于近日收到国家药品监督管理局颁发的《医疗器械注册证》，涉及产品：“血液透析浓缩物”。天益药业本次获得医疗器械注册证的血液透析浓缩物由分为A浓缩液(以下简称A液)和联机B干粉(以下简称B粉)组成。A液由氯化钠、氯化钾、氯化钙、氯化镁、冰醋酸和透析用水组成，B粉由碳酸氢钠组成。A液型号分别为TR-YA3-01、TR-YA3-02，规格分别为5L\\桶、10L\\桶。B粉型号为TR-FB-LBT1，规格为650g\\筒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"天益医疗(301097.SZ)：“血液透析浓缩物”取得产品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2607053038","title":"股市必读：天益医疗(301097)股东户数0.57万户，较上期增加10.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607053038","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607053038?lang=zh_cn&edition=full","pubTime":"2026-01-30 03:52","pubTimestamp":1769716332,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，天益医疗报收于57.99元，下跌0.72%，换手率3.96%，成交量1.15万手，成交额6792.42万元。当日关注点来自交易信息汇总：1月29日主力资金净流入36.3万元，游资资金净流入122.86万元，散户资金呈净流出状态。来自股本股东变化：截至2026年1月20日，公司股东户数环比增长10.93%，户均持股数量下降至1.03万股。股本股东变化股东户数变动近日天益医疗披露，截至2026年1月20日公司股东户数为5696.0户，较12月10日增加561.0户，增幅为10.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000004161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301097"],"gpt_icon":0},{"id":"2607722493","title":"天益医疗：截至2026年1月20日，公司股东数量共计5,696名","url":"https://stock-news.laohu8.com/highlight/detail?id=2607722493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607722493?lang=zh_cn&edition=full","pubTime":"2026-01-29 08:39","pubTimestamp":1769647151,"startTime":"0","endTime":"0","summary":"证券之星消息，天益医疗(301097)01月28日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好:请问目前为止股东人数是多少？谢谢天益医疗回复：尊敬的投资者，截至2026年1月20日，公司股东数量共计5,696名，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900006686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2606781230","title":"信达证券：首次覆盖天益医疗给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2606781230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606781230?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:39","pubTimestamp":1769517540,"startTime":"0","endTime":"0","summary":"信达证券股份有限公司唐爱金,贺鑫,曹佳琳近期对天益医疗进行研究并发布了研究报告《公司深度报告：深耕血液净化黄金赛道，内生外延构建长期成长曲线》，首次覆盖天益医疗给予买入评级。天益 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260127/c674349074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["601059","301097"],"gpt_icon":0},{"id":"2604318847","title":"天益医疗获医疗器械注册证 承担血液及液体通路功能","url":"https://stock-news.laohu8.com/highlight/detail?id=2604318847","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604318847?lang=zh_cn&edition=full","pubTime":"2026-01-19 14:18","pubTimestamp":1768803480,"startTime":"0","endTime":"0","summary":"1月19日，天益医疗（301097）发布公告，公司近日收到国家药品监督管理局颁发的《医疗器械注册证》。该产品由多种管路和附件组成，适用于与AQUARIUS系列连续性血液净化装置和专用滤器配套使用，承担血液及液体通路的功能。此次注册证的获得，标志着公司产品持续符合相关监管要求，有助于巩固和扩大市场竞争力。2025年前三季度，天益医疗实现收入3.87亿元，归母净利润2009万元。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2026-01-19/doc-inhhvmxx6933356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09997","BK0251","301097","159883","BK1222","BK1574","BK1583","BK1100","09996"],"gpt_icon":0},{"id":"2604904378","title":"天益医疗(301097.SZ)新产品取得产品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2604904378","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604904378?lang=zh_cn&edition=full","pubTime":"2026-01-19 11:46","pubTimestamp":1768794383,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天益医疗(301097.SZ)发布公告，公司于近日收到国家药品监督管理局颁发的《医疗器械注册证》，产品名称：一次性使用连续性肾脏替代治疗管路。本次获得注册证的一次性使用连续性肾脏替代治疗管路，是一套完整集成、专业可靠的体外循环管路系统，其高度集成的多管路设计与完备的安全配件，能够更好地满足重症监护环境下连续性肾脏替代治疗的临床操作与安全需求，适配于日机装Aquarius血液净化设备。本次获得注册证书，为公司相关产品注册证书的顺利展期，证明公司产品持续符合相关监管要求，对巩固和扩大市场竞争力具有积极意义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"天益医疗(301097.SZ)新产品取得产品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2602518544","title":"天益医疗(301097.SZ)拟6000万元至1.2亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2602518544","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602518544?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:30","pubTimestamp":1768210236,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天益医疗(301097.SZ)发布公告，公司拟使用自有资金及银行贷款以集中竞价方式回购公司部分已发行的人民币普通股(A股)股票，用于实施股权激励或员工持股计划。本次拟回购的资金总额不低于人民币6,000万元(含)且不超过人民币1.2亿元(含)，回购价格不超过人民币65元/股(含)，回购期限自董事会审议通过本次回购股份方案之日起12个月内，即2026年1月12日至2027年1月11日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2594294409","title":"天益医疗（301097）披露更换保荐代表人公告，12月26日股价上涨0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594294409","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594294409?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:42","pubTimestamp":1766760137,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，天益医疗报收于52.11元，较前一交易日上涨0.42%，最新总市值为30.72亿元。该股当日开盘51.66元，最高52.94元，最低51.39元，成交额达5720.48万元，换手率为3.78%。同日，天益医疗发布公告称，公司收到国泰海通证券股份有限公司关于更换持续督导保荐代表人的函。原保荐代表人栾俊先生因工作变动无法继续履行相关职责，现由黄振东先生接替其负责公司的持续督导工作。公司对栾俊先生在任职期间所做出的贡献表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600036740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2591437617","title":"天益医疗（301097）披露董事会完成换届选举及聘任高级管理人员公告，12月15日股价上涨2.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591437617","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591437617?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:07","pubTimestamp":1765793233,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，天益医疗报收于54.05元，较前一交易日上涨2.43%，最新总市值为31.86亿元。近日，宁波天益医疗器械股份有限公司发布公告称，公司已完成董事会换届选举，选举吴志敏为董事长，吴志敏、吴斌、江厚佳、张重良为非独立董事，刘起贵、郑一峰、章定表为独立董事，并成立董事会各专门委员会。上述任职人员任期自董事会审议通过之日起至第四届董事会任期届满之日止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500023873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301097"],"gpt_icon":0},{"id":"2590593764","title":"天益医疗：截至2025年12月10日股东数为5,135户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590593764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590593764?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440922,"startTime":"0","endTime":"0","summary":"证券之星消息，天益医疗(301097)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，贵公司截止目前股东户数为多少？天益医疗回复：你好，截至2025年12月10日，公司股东数为5,135户，谢谢以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100022115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301097","BK0251"],"gpt_icon":0},{"id":"2589339376","title":"天益医疗（301097）披露选举第四届董事会成员，12月08日股价下跌2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589339376","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589339376?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:52","pubTimestamp":1765187551,"startTime":"0","endTime":"0","summary":"截至2025年12月8日收盘，天益医疗报收于55.4元，较前一交易日下跌2.33%，最新总市值为32.66亿元。该股当日开盘57.01元，最高57.29元，最低55.08元，成交额达5722.58万元，换手率为3.54%。公司近日发布公告称，宁波天益医疗器械股份有限公司于2025年12月5日召开2025年第三次临时股东会，审议通过了选举第四届董事会非独立董事和独立董事的议案。公告显示，吴志敏、吴斌、江厚佳当选为非独立董事，郑一峰、刘起贵、章定表当选为独立董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301097"],"gpt_icon":0},{"id":"2585689894","title":"天益医疗(301097)11月20日股东户数0.52万户，较上期减少8.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585689894","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585689894?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:52","pubTimestamp":1763977977,"startTime":"0","endTime":"0","summary":"证券之星消息，近日天益医疗披露，截至2025年11月20日公司股东户数为5206.0户，较11月10日减少483.0户，减幅为8.49%。在医疗器械行业个股中，天益医疗股东户数低于行业平均水平，截至11月20日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年11月10日至2025年11月20日，天益医疗区间跌幅为0.7%，在此期间股东户数减少483.0户，减幅为8.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400022903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301097"],"gpt_icon":0},{"id":"2585190019","title":"11月21日天益医疗跌5.93%，鹏华安和混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585190019","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585190019?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:04","pubTimestamp":1763712272,"startTime":"0","endTime":"0","summary":"证券之星消息，11月21日天益医疗跌5.93%，收盘报55.65元，换手率5.47%，成交量1.58万手，成交额9006.22万元。重仓天益医疗的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为鹏华基金的鹏华安和混合A。鹏华安和混合A目前规模为1.9亿元，最新净值1.3999，较上一交易日下跌0.19%，近一年上涨11.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100019174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301097"],"gpt_icon":0},{"id":"2584218731","title":"天益医疗（301097）披露新产品取得产品注册证书，11月20日股价上涨1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584218731","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584218731?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:48","pubTimestamp":1763632111,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，天益医疗报收于59.16元，较前一交易日上涨1.58%，最新总市值为34.87亿元。该股当日开盘58.38元，最高59.99元，最低57.86元，成交额达8012.02万元，换手率为4.69%。公司近日发布公告称，其子公司宁波天益药业科技有限公司收到国家药品监督管理局颁发的《医疗器械注册证》，产品名称为血液透析浓缩物，注册证编号国械注准20253102303，注册类别III类，有效期至2030年11月12日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000026972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","301097"],"gpt_icon":0},{"id":"2584390901","title":"天益医疗(301097.SZ)子公司血液透析浓缩物取得产品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2584390901","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584390901?lang=zh_cn&edition=full","pubTime":"2025-11-20 11:40","pubTimestamp":1763610059,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天益医疗 发布公告，公司子公司宁波天益药业科技有限公司于近日收到国家药品监督管理局颁发的《医疗器械注册证》。天益药业本次获得医疗器械注册证的血液透析浓缩物分为A浓缩液和联机B干粉组成。该注册证的取得进一步延长了公司产品链，丰富了公司产品类别，有利于提高公司综合竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"天益医疗(301097.SZ)子公司血液透析浓缩物取得产品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","301097"],"gpt_icon":0},{"id":"2584343915","title":"11月19日天益医疗跌5.35%，鹏华安和混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584343915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584343915?lang=zh_cn&edition=full","pubTime":"2025-11-19 15:51","pubTimestamp":1763538699,"startTime":"0","endTime":"0","summary":"证券之星消息，11月19日天益医疗跌5.35%，收盘报58.24元，换手率6.03%，成交量1.75万手，成交额1.02亿元。重仓天益医疗的公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为鹏华基金的鹏华安和混合A。鹏华安和混合A目前规模为1.9亿元，最新净值1.4098，较上一交易日下跌0.2%，近一年上涨14.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900021537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301097","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772490106844,"stockEarnings":[{"period":"1week","weight":0.0275},{"period":"1month","weight":-0.0512},{"period":"3month","weight":-0.0035},{"period":"6month","weight":0.2952},{"period":"1year","weight":0.3721},{"period":"ytd","weight":0.1015}],"compareEarnings":[{"period":"1week","weight":0.0246},{"period":"1month","weight":0.0157},{"period":"3month","weight":0.0731},{"period":"6month","weight":0.0968},{"period":"1year","weight":0.2595},{"period":"ytd","weight":0.0539}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波天益医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"4958人(较上一季度减少4.01%)","perCapita":"5837股","listingDate":"2022-04-07","address":"浙江省宁波市鄞州区东钱湖旅游度假区莫枝北路788号","registeredCapital":"5894万元","survey":" 宁波天益医疗器械股份有限公司的主营业务是血液净化及病房护理领域医用高分子耗材等医疗器械的研发、生产与销售。公司的主要产品是血液净化装置的体外循环血路、一次性使用动静脉穿刺器、血液透析浓缩液/血液透析干粉、一次性使用一体式吸氧管、喂食器及喂液管。","listedPrice":52.37},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"天益医疗(301097)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天益医疗(301097)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天益医疗,301097,天益医疗股票,天益医疗股票老虎,天益医疗股票老虎国际,天益医疗行情,天益医疗股票行情,天益医疗股价,天益医疗股市,天益医疗股票价格,天益医疗股票交易,天益医疗股票购买,天益医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天益医疗(301097)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天益医疗(301097)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}